wxbcvanpu
2021-02-03
什么意思呢
ROCE Insights For Bionano Genomics<blockquote>ROCE 对 Bionano Genomics 的见解</blockquote>
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":314045955,"tweetId":"314045955","gmtCreate":1612281975977,"gmtModify":1703759960180,"author":{"id":3566212400811103,"idStr":"3566212400811103","authorId":3566212400811103,"authorIdStr":"3566212400811103","name":"wxbcvanpu","avatar":"https://static.tigerbbs.com/4b24368ca481cf01f78abb3439ce4272","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":9,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body><p>什么意思呢</p></body></html>","htmlText":"<html><head></head><body><p>什么意思呢</p></body></html>","text":"什么意思呢","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/314045955","repostId":2108398627,"repostType":2,"repost":{"id":"2108398627","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga Earnings","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1612284397,"share":"https://www.laohunote.com/m/news/2108398627?lang=zh_CN&edition=full","pubTime":"2021-02-03 00:46","market":"hk","language":"en","title":"ROCE Insights For Bionano Genomics<blockquote>ROCE 对 Bionano Genomics 的见解</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2108398627","media":"Benzinga Earnings","summary":"During Q3, Bionano Genomics's (NASDAQ:BNGO) reported sales totaled $2.20 million. Despite a 37.55% in earnings, the company posted a loss of $10.23 million. Bionano Genomics collected $1.18 million in revenue during Q2, but reported earnings showed a $7.43 million loss.","content":"<p><html><body>During Q3, <strong><a href=\"https://laohu8.com/S/BNGO\">Bionano Genomics</a></strong>'s (NASDAQ:BNGO) reported sales totaled $2.20 million. Despite a 37.55% in earnings, the company posted a loss of $10.23 million. Bionano Genomics collected $1.18 million in revenue during Q2, but reported earnings showed a $7.43 million loss.</p><p><blockquote><html><body>第三季度期间，<strong><a href=\"https://laohu8.com/S/BNGO\">生物纳米基因组学</a></strong>（纳斯达克股票代码：BNGO）报告销售额总计 220 万美元。尽管盈利增长了 37.55%，但该公司仍亏损 1023 万美元。Bionano Genomics 第二季度收入为 118 万美元，但公布的收益显示亏损 743 万美元。</body></html></blockquote></p><p> <h3>What Is ROCE?</h3> Changes in earnings and sales indicate shifts in Bionano Genomics's Return on Capital Employed, a measure of yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q3, Bionano Genomics posted an ROCE of -0.7%.</p><p><blockquote><h3>什么是ROCE？</h3>收益和销售额的变化表明 Bionano Genomics 的资本回报率发生变化，资本回报率是衡量企业相对于资本的年度税前利润的指标。一般来说，较高的 ROCE 表明公司成功发展，也是未来每股收益较高的标志。第三季度，Bionano Genomics 的 ROCE 为 -0.7%。</blockquote></p><p> It is important to keep in mind ROCE evaluates past performance and is not used as a predictive tool. It is a good measure of a company's recent performance, but several factors could affect earnings and sales in the near future.</p><p><blockquote>重要的是要记住，ROCE评估过去的表现，而不是用作预测工具。这是衡量公司近期业绩的一个很好的指标，但有几个因素可能会影响近期的收益和销售。</blockquote></p><p> Return on Capital Employed is an important measurement of efficiency and a useful tool when comparing companies that operate in the same industry. A relatively high ROCE indicates a company may be generating profits that can be reinvested into more capital, leading to higher returns and growing EPS for shareholders.</p><p><blockquote>资本回报率是衡量效率的一个重要指标，也是比较同行业公司时的一个有用工具。相对较高的 ROCE 表明公司可能正在产生利润，这些利润可以再投资于更多资本，从而为股东带来更高的回报和不断增长的每股收益。</blockquote></p><p> For Bionano Genomics, the return on capital employed ratio shows the current amount of assets may not actually be helping the company achieve higher returns, a note many investors will take into account when making long-term financial decisions.</p><p><blockquote>对于 Bionano Genomics 来说，资本使用回报率表明当前的资产数量可能实际上并不能帮助公司实现更高的回报，许多投资者在做出长期财务决策时会考虑到这一点。</blockquote></p><p> <h3>Q3 Earnings Recap</h3> Bionano Genomics reported Q3 earnings per share at $-0.08/share, which did not meet analyst predictions of $-0.05/share.</p><p><blockquote><h3>第三季度收益回顾</h3>Bionano Genomics 公布的第三季度每股收益为-0.08 美元/股，未达到分析师预测的-0.05 美元/股。</blockquote></p><p> </body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ROCE Insights For Bionano Genomics<blockquote>ROCE 对 Bionano Genomics 的见解</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nROCE Insights For Bionano Genomics<blockquote>ROCE 对 Bionano Genomics 的见解</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga Earnings </p>\n<p class=\"h-time smaller\">2021-02-03 00:46</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><html><body>During Q3, <strong><a href=\"https://laohu8.com/S/BNGO\">Bionano Genomics</a></strong>'s (NASDAQ:BNGO) reported sales totaled $2.20 million. Despite a 37.55% in earnings, the company posted a loss of $10.23 million. Bionano Genomics collected $1.18 million in revenue during Q2, but reported earnings showed a $7.43 million loss.</p><p><blockquote><html><body>第三季度期间，<strong><a href=\"https://laohu8.com/S/BNGO\">生物纳米基因组学</a></strong>（纳斯达克股票代码：BNGO）报告销售额总计 220 万美元。尽管盈利增长了 37.55%，但该公司仍亏损 1023 万美元。Bionano Genomics 第二季度收入为 118 万美元，但公布的收益显示亏损 743 万美元。</body></html></blockquote></p><p> <h3>What Is ROCE?</h3> Changes in earnings and sales indicate shifts in Bionano Genomics's Return on Capital Employed, a measure of yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q3, Bionano Genomics posted an ROCE of -0.7%.</p><p><blockquote><h3>什么是ROCE？</h3>收益和销售额的变化表明 Bionano Genomics 的资本回报率发生变化，资本回报率是衡量企业相对于资本的年度税前利润的指标。一般来说，较高的 ROCE 表明公司成功发展，也是未来每股收益较高的标志。第三季度，Bionano Genomics 的 ROCE 为 -0.7%。</blockquote></p><p> It is important to keep in mind ROCE evaluates past performance and is not used as a predictive tool. It is a good measure of a company's recent performance, but several factors could affect earnings and sales in the near future.</p><p><blockquote>重要的是要记住，ROCE评估过去的表现，而不是用作预测工具。这是衡量公司近期业绩的一个很好的指标，但有几个因素可能会影响近期的收益和销售。</blockquote></p><p> Return on Capital Employed is an important measurement of efficiency and a useful tool when comparing companies that operate in the same industry. A relatively high ROCE indicates a company may be generating profits that can be reinvested into more capital, leading to higher returns and growing EPS for shareholders.</p><p><blockquote>资本回报率是衡量效率的一个重要指标，也是比较同行业公司时的一个有用工具。相对较高的 ROCE 表明公司可能正在产生利润，这些利润可以再投资于更多资本，从而为股东带来更高的回报和不断增长的每股收益。</blockquote></p><p> For Bionano Genomics, the return on capital employed ratio shows the current amount of assets may not actually be helping the company achieve higher returns, a note many investors will take into account when making long-term financial decisions.</p><p><blockquote>对于 Bionano Genomics 来说，资本使用回报率表明当前的资产数量可能实际上并不能帮助公司实现更高的回报，许多投资者在做出长期财务决策时会考虑到这一点。</blockquote></p><p> <h3>Q3 Earnings Recap</h3> Bionano Genomics reported Q3 earnings per share at $-0.08/share, which did not meet analyst predictions of $-0.05/share.</p><p><blockquote><h3>第三季度收益回顾</h3>Bionano Genomics 公布的第三季度每股收益为-0.08 美元/股，未达到分析师预测的-0.05 美元/股。</blockquote></p><p> </body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"https://www.benzinga.com/node/19445351","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2108398627","content_text":"During Q3, Bionano Genomics's (NASDAQ:BNGO) reported sales totaled $2.20 million. Despite a 37.55% in earnings, the company posted a loss of $10.23 million. Bionano Genomics collected $1.18 million in revenue during Q2, but reported earnings showed a $7.43 million loss.\nWhat Is ROCE?\nChanges in earnings and sales indicate shifts in Bionano Genomics's Return on Capital Employed, a measure of yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q3, Bionano Genomics posted an ROCE of -0.7%.\nIt is important to keep in mind ROCE evaluates past performance and is not used as a predictive tool. It is a good measure of a company's recent performance, but several factors could affect earnings and sales in the near future.\nReturn on Capital Employed is an important measurement of efficiency and a useful tool when comparing companies that operate in the same industry. A relatively high ROCE indicates a company may be generating profits that can be reinvested into more capital, leading to higher returns and growing EPS for shareholders.\nFor Bionano Genomics, the return on capital employed ratio shows the current amount of assets may not actually be helping the company achieve higher returns, a note many investors will take into account when making long-term financial decisions.\nQ3 Earnings Recap\nBionano Genomics reported Q3 earnings per share at $-0.08/share, which did not meet analyst predictions of $-0.05/share.","news_type":1,"symbols_score_info":{"BNGO":1}},"isVote":1,"tweetType":1,"viewCount":1459,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":10,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/314045955"}
精彩评论